Gen-Next Probiotics and Microbiome Congress (San Diego, CA, United States - February 6-7, 2020) - ResearchAndMarkets.com

DUBLIN--()--The "Gen-Next Probiotics and Microbiome Congress" conference has been added to ResearchAndMarkets.com's offering.

What are the essentials being missed out on? Witness the major breakthroughs of microbial research and application pertaining to challenges like medicinal data interpretation, investment and regulatory hurdles faced by the practitioners. The intersection between emerging technology and discovery with the context of consumer interest. Detect the non-identified dysbiosis, to discover the potential areas under study for investments in Gut and Skin microbiome and its role as a diagnostic tool of pharmaceutical discovery.

  • Major breakthroughs of microbial research and applications
  • Challenges associated with medicinal data interpretation, investments and regulatory hurdles
  • Detection of non-identified dysbiosis to discover potential research areas with increasing investments in gut and skin microbiome

Join us at Gen-Next Probiotics and Microbiome Congress, 2020 to network with biotech, pharma, academicians and investors to exchange views and observe the most ingenious research and technologies. Understand what's happening. Witness the amalgamation of study focused on pharmaceutical and medicinal approaches of probiotics and the nutraceutical and consumer approaches along with the role of microbiome in clinical applications and preventative medicine.

Key Highlights

  • Microbial Innovations
  • Gut and Skin Microbiota
  • Regulatory Issues
  • Live Probiotic Technology
  • Strain Identification
  • Fecal Microbiota & Engineered Microbiome
  • Commercialization and Marketing

Who Should Attend:

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of:

Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the departments of:

  • Microbiome discovery
  • Microbiome science
  • Microbiology
  • Human microbiome
  • Drug discovery
  • Therapeutics
  • Immunotherapy
  • Microbiology
  • Microbiome therapeutics
  • Microbiome
  • Gastroenterology
  • Immunology
  • Bioinformatics
  • Obstetrics
  • Neonatology
  • Pediatrics
  • Nutritionists/dieticians

Agenda:

Day 1

07:55 - 08:55 Registration

08:55 - 09:00 Opening note

09:00 - 09:05 Opening remarks by Chairman

09:05 - 09:35 Keynote presentation

Emerging Trends In Microbiome

09:35 - 10:05 Microbiome in Preventative medicine- Pave the way towards Future and Beyond

10:05 - 10:35 Solution provider presentation

10:35 - 11:25 Morning refreshment and Networking

11:25 - 11:55 Use of Supply chain to produce treatments developed through live bacteria

11:55 - 12:25 Potential Role of Next-Generation Sequencing in Disease Diagnosis and Treatment

12:25 - 12:55 Solution provider presentation

12:55 - 13:55 Lunch and Networking

Developments In Microbiome Therapeutics

13:55 - 14:25 Rising Developments in Microbiome and Microglia Research: Implications for Neurodevelopmental Disorders

14:25 - 14:55 The Human Microbiome: A New Protagonist in managing Human Health

14:55 - 15:25 Solution provider presentation

15:25 - 15:55 Afternoon Refreshments and Networking

15:55 - 16:25 Panel Discussion: Microbiome therapeutics - just publicity or is it occurring?

16:25 - 16:55 Gut Microbiota and Cancer: From Pathogenesis to Therapy

16:55 - 17:25 Impact of the microbiome in the gut-brain axis

17:30 - 18:30 Drink Reception & Networking

Day 2

08:30 - 08:55 Registration

Clinical Application Of Microbiome

09:05 - 09:35 Microbiome- A diagnostic tool of pharmaceutical R&D and discovery

09:35 - 10:05 Role of Skin Microbiota in cutaneous health and disease

10:05 - 10:35 Solution provider presentation

10:35 - 11:25 Morning refreshment and Networking

11:25 - 12:05 Panel Discussion: State of current Innovation and Future integration of microbiome-based approaches into Routine oncology practice

12:05 - 12:40 Clinical and preclinical trials result in immune-checkpoint and microbiome

12:40 - 13:10 Solution provider presentation

13:10 - 14:10 Lunch Break and Networking

Funding And Regulatory Hurdles

14:10 - 14:40 Working on 3 I's for success- Developing an IP strategy for attracting Insurers and Investors

14:40 - 15:10 Impact of current regulatory body on microbiome-based therapies

15:10 - 15:40 FDA in anticancer novel probiotics- A systematic overview

15:40 - 16:10 Emerging FDA regulations: Understanding the microbiome-based product regulations

For more information about this conference visit https://www.researchandmarkets.com/r/nqiuj1

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900